Join the Oncology Voice Network. Join for Free
MSL Burnout...The Struggle is Real
MSL burnout stress management Medical Science Liaisons post-COVID challenges supportive teams

MSL Burnout...The Struggle is Real


Share This Article


Summary

In this episode, Jennifer Mohawk joins to discuss the prevalent issue of burnout among Medical Science Liaisons. She shares her insights on the common stressors, including overachievement and post-COVID challenges, that contribute to burnout in the MSL field. Jennifer addresses the impact of travel stress and the pressure of metrics, emphasizing the importance of recognizing early warning signs. She provides effective strategies for managing stress, such as midday movement and aligning personal and organizational values. The episode concludes with Jennifer's advice on building supportive, diverse teams and her final words of wisdom for MSLs.

My guest this week is Jennifer Mohawk, Senior Director, Medical Affairs with Apogee Therapeutics who discusses MSL burnout and how to handle the stress of the job.

Jen shares….

👉 What is MSL Burnout?
👉 How to pick up the warning signs
👉 What Managers can do to help with burnout
👉 What are ways to minimize and cope with the stress of the job
👉 What habits should be adopted for MSL sanity

Click for Source
MSL burnout, stress management, Medical Science Liaisons, post-COVID challenges, supportive teams

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
How to Start Presenting Like a Pro
Partner Avatar MSL Talk: Tom Caravela

How to Start Presenting Like a Pro

Article
Value assessment of oncology drugs using a weighted criterion-based approach
OVN Avatar Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer

Value assessment of oncology drugs using a weighted criterion-based approach

Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
OVN Avatar Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Article
Outcome measures for oncology alternative payment models: practical considerations and recommendations
OVN Avatar Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD

Outcome measures for oncology alternative payment models: practical considerations and recommendations

Article
Leveraging existing data to contextualize phase II clinical trial findings in oncology
OVN Avatar E.M. Ray, L.A. Carey, K.E. Reeder-Hayes

Leveraging existing data to contextualize phase II clinical trial findings in oncology

Explore OVN